Table 1.
n samples analyzed | MOG antibody+ | AQP4 antibody+ | NMDAR antibody+ | Remaining seronegative | |
---|---|---|---|---|---|
Seronegative “NMO suspects” cohort* |
146 | 21 | 8 | 2 | 115 |
MS controls | 20 | 1 | 0 | 1 | 18 |
Previously seronegative for AQP4 antibodies. MOG = myelin oligodendrocyte glycoprotein. AQP4 = aquaporin four. NMDAR = N-Methyl-D-aspartate receptor. MS = multiple sclerosis.